Skip to main content

Cigna Group

corporate_fare Company Profile

Cigna Group

CI·NYSE·Life Sciences·CIK 0001739940

The Cigna Group is a global health company with approximately 67,700 colleagues. The company serves more than 185 million customer relationships in over 30 markets and jurisdictions as of December 31, 2025. It also maintains approximately 1.7 million relationships with health care providers, clinics, and facilities. The Cigna Group operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment delivers independent and coordinated health solutions and capabilities through its Pharmacy Benefit Services and Specialty and Care Services operating segments. Cigna Healthcare, the health benefits segment, offers comprehensive medical and coordinated solutions to customers and clients through its U.S. Healthcare and International Health operating segments. These two segments integrate pharmacy and medical capabilities to enhance affordability, transparency, and health outcomes.

Cigna Group (NYSE:CI) is a publicly traded company in the Life Sciences sector. Wiseek monitors CI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Cigna Ends GLP-1 Obesity Drug Coverage for Employees, Effective July 1
  • Cigna Reports Strong Q1 2026 Earnings with 25% Net Income Growth and Increased Dividend
  • Cigna Group Reports Strong Q1 Results, Raises Full-Year 2026 Outlook
  • Cigna Beats Q1 Revenue Estimates, Raises Full-Year Guidance
  • Cigna Group Details CEO Transition, New Board Leadership, and Shareholder Proposals in Definitive Proxy Statement

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$274.9B
Net Income
$5.96B
Diluted EPS
$22.18
Op. Cash Flow
$9.6B
Gross Profit
$59.91B
Operating Income
$9.2B
Cash & Equivalents
$7.68B
Total Debt
$592M
Debt / Equity
0.01×
Net Margin
2.2%
Shares Outstanding
263.46M sh
Source: 10-K · filed 2026-02-26 · accession 0001739940-26-000006
Browse all tickers starting with C →
$296.9 +1.09% today
52-week range · as of 2026-04-30 $239.51 – $350
Market cap
$77.99B
Volume
1.1M (0.7× avg)
3-mo avg 1.7M
Live data · 2026-06-12 13:01 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed CI - Latest Insights

CI
Jun 02, 2026, 5:41 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $272.72
Real-time Price: $296.90 info
Change: +$24.18 (+9%) info
Market Cap: $77.995B info
CI
Apr 30, 2026, 11:47 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $291.77
Real-time Price: $296.90 info
Change: +$5.13 (+2%) info
Market Cap: $77.995B info
CI
Apr 30, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $293.01
Real-time Price: $296.90 info
Change: +$3.89 (+1%) info
Market Cap: $77.995B info
CI
Apr 30, 2026, 6:08 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $291.00
Real-time Price: $296.90 info
Change: +$5.90 (+2%) info
Market Cap: $77.995B info
CI
Mar 13, 2026, 4:36 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $267.19
Real-time Price: $296.90 info
Change: +$29.71 (+11%) info
Market Cap: $77.995B info
CI
Mar 03, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $284.01
Real-time Price: $296.90 info
Change: +$12.89 (+5%) info
Market Cap: $77.995B info
CI
Mar 03, 2026, 7:42 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $280.00
Real-time Price: $296.90 info
Change: +$16.90 (+6%) info
Market Cap: $77.995B info
CI
Feb 26, 2026, 12:08 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $286.72
Real-time Price: $296.90 info
Change: +$10.18 (+4%) info
Market Cap: $77.995B info
CI
Feb 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $271.00
Real-time Price: $296.90 info
Change: +$25.90 (+10%) info
Market Cap: $77.995B info